Generics (UK)

Generics (UK) is a major pharmaceutical company based in the United Kingdom, currently operating as a core subsidiary of Viatris following the merger of Mylan and Pfizer's Upjohn division. The company is a leading supplier of generic medicines and biosimilars to the National Health Service (NHS), maintaining an extensive portfolio that covers a wide range of therapeutic areas including oncology, cardiology, and immunology. By providing high-quality, cost-effective alternatives to off-patent branded medications, Generics (UK) plays a critical role in the sustainability of the UK healthcare system. Its operations include the development, regulatory filing, and distribution of complex generics and biological products. The entity remains one of the largest employers in the UK pharmaceutical sector, headquartered in Potters Bar.